Novo’s Tresiba primed for key ‘hypo’ label update in EU
Fast-acting insulin also approved in US
X
Novo’s Tresiba primed for key ‘hypo’ label update in EU
https://pharmaphorum.com/news/novos-tresiba-gets-key-hypo-label-update-eu/
Fast-acting insulin also approved in US
